Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic

被引:83
作者
Frazier, L
Turner, ST
Schwartz, GL
Chapman, AB
Boerwinkle, E
机构
[1] Univ Texas, Houston Sch Nursing, Ctr Human Genet, Houston, TX USA
[2] Inst Mol Med, Houston, TX USA
[3] Mayo Clin & Mayo Fdn, Div Hypertens, Rochester, MN 55905 USA
[4] Emory Univ, Div Renal, Atlanta, GA 30322 USA
关键词
hypertension; diuretics; genetics; RAA system; African-Americans; gender; polymorphisms;
D O I
10.1038/sj.tpj.6500215
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The renin - angiotensin - aldosterone (RAA) system regulates blood pressure ( BP) levels and influences responses to antihypertensive medications. Variation in RAA system genes has been reported to influence interindividual differences in BP levels and the occurrence of hypertension (HTN). Methods: We evaluated the relationship between variation in genes of the RAA system and interindividual differences in BP response to a thiazide diuretic. Analyses were carried out in a race- and gender-specific manner in 255 unrelated hypertensive African-Americans ( 125 men and 130 women) and 246 unrelated hypertensive non-Hispanic Whites ( 133 men and 113 women). Results: The angiotensin II receptor ( AT(1)R) A1166C and angiotensinogen G-6A polymorphisms had a significant effect on systolic BP response to the diuretic in African-American women. Multilocus analyses indicated that the effects of these genes combined additively to influence response. Results of a permutation test to adjust for multiple comparisons and the possible nonindependence among genotypes remained significant at the P = 0.003 level. Conclusions: Among African-American women, particular gene variations in the RAA system have additive effects on BP response to a thiazide diuretic.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 23 条
[1]  
BEEVERS GD, 1999, HYPERTENSION PRACTIC
[2]   Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension [J].
Chapman, AB ;
Schwartz, GL ;
Boerwinkle, E ;
Turner, ST .
KIDNEY INTERNATIONAL, 2002, 61 (03) :1047-1055
[3]   Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes [J].
Duncan, JA ;
Scholey, JW ;
Miller, JA .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (01) :111-116
[4]  
ELLIOTT W, 2000, HYPERTENSION THERAPY
[5]  
Fox S. I., 1984, HUMAN PHYSL
[6]   Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis [J].
Halushka, MK ;
Fan, JB ;
Bentley, K ;
Hsie, L ;
Shen, NP ;
Weder, A ;
Cooper, R ;
Lipshutz, R ;
Chakravarti, A .
NATURE GENETICS, 1999, 22 (03) :239-247
[7]  
Hingorani AD, 1995, J HYPERTENS, V13, P1602
[8]   Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene [J].
Hunt, SC ;
Geleijnse, JM ;
Wu, LL ;
Witteman, JCM ;
Williams, RR ;
Grobbee, DE .
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (05) :460-466
[9]   A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro [J].
Inoue, I ;
Nakajima, T ;
Williams, CS ;
Quackenbush, J ;
Puryear, R ;
Powers, M ;
Cheng, T ;
Ludwig, EH ;
Sharma, AM ;
Hata, A ;
Jeunemaitre, X ;
Lalouel, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1786-1797
[10]   Haplotypes of angiotensinogen in essential hypertension [J].
Jeunemaitre, X ;
Inoue, I ;
Williams, C ;
Charru, A ;
Tichet, J ;
Powers, M ;
Sharma, AM ;
GimenezRoqueplo, AP ;
Hata, A ;
Corvol, P ;
Lalouel, JM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (06) :1448-1460